- Home
- MTLS vs SLP Comparison
MTLS vs SLP Comparison
Compare MTLS & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTLS | SLP |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | EDP Services |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.9M | 326.7M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MTLS | SLP |
|---|---|---|
| Price | $6.63 | $18.18 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 162.2K | ★ 443.7K |
| Earning Date | 05-07-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | $6.38 | $3.80 |
| Revenue Next Year | $6.45 | $5.90 |
| P/E Ratio | ★ $61.39 | $69.81 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $4.78 | $11.09 |
| 52 Week High | $7.00 | $21.01 |
Technical Indicators
Market Signals| Indicator | MTLS | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 59.38 | 67.04 |
| Support Level | $5.44 | $17.74 |
| Resistance Level | $6.89 | $18.76 |
| Average True Range (ATR) | 0.26 | 0.51 |
| MACD | -0.05 | 0.12 |
| Stochastic Oscillator | 41.96 | 86.67 |
Price Performance
Historical ComparisonAbout MTLS Materialise NV
Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.